Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kozo Morimoto

Showing results (161-170 of 191) with videos related to

Pageof 20
Sort By:
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|October 16, 2020
Analysis of risk factors for the development of a post-bronchoscopy respiratory infection in lung cancer patientsMasafumi Shimoda, Kazunari Yamana, Ryozo Yano, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 12, 2017
Clinical characteristics of pulmonary Mycobacterium lentiflavum disease in adult patientsKazuma Yagi, Kozo Morimoto, Makoto Ishii, et al.
Medicine|December 10, 2021
In-hospital pulmonary rehabilitation after completion of primary respiratory disease treatment improves physical activity and ADL performance: A prospective intervention studyMasafumi Shimoda, Satoshi Takao, Hiroyuki Kokutou, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 11, 2017
Clinical Significance of Interferon-γ Neutralizing Autoantibodies Against Disseminated Nontuberculous Mycobacterial DiseaseAmi Aoki, Takuro Sakagami, Kazutaka Yoshizawa, et al.
ERJ Open Research|February 23, 2023
Epidemiological characteristics of nontuberculous mycobacteriosis and bronchiectasis: comparative study using national mortality statistics from 1970 to 2015 in JapanKozo Morimoto, Kazuro Iwai, Takashi Yoshiyama, et al.
Diagnostic Microbiology and Infectious Disease|August 15, 2021
Evaluation of IS1245 LAMP in Mycobacterium avium and the influence of host-related genetic diversity on its applicationMwangala Lonah Akapelwa, Thoko Flav Kapalamula, Yuki Ouchi-Aizu, et al.
BMC Infectious Diseases|August 11, 2016
Clinical efficacy and safety of multidrug therapy including thrice weekly intravenous amikacin administration for Mycobacterium abscessus pulmonary disease in outpatient settings: a case seriesHo Namkoong, Kozo Morimoto, Tomoyasu Nishimura, et al.
Chest|September 19, 2023
Activities of Daily Living, Hypoxemia, and Lymphocytes Score for Predicting Mortality Risk in Patients With Pulmonary TBTakeshi Osawa, Masato Watanabe, Kozo Morimoto, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 9, 2025
Clinical characteristics of extrapulmonary nontuberculous mycobacterial disease in Japanese adult patients without HIV: A multicenter retrospective studyShuhei Azekawa, Takanori Asakura, Shunsuke Uno, et al.
Annals of the American Thoracic Society|August 12, 2016
Macrolide-Resistant Mycobacterium avium Complex Lung Disease: Analysis of 102 Consecutive CasesKozo Morimoto, Ho Namkoong, Naoki Hasegawa, et al.
Pageof 20

Showing results (161-170 of 191) with videos related to

Sort By:
Pageof 20
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|October 16, 2020
Analysis of risk factors for the development of a post-bronchoscopy respiratory infection in lung cancer patientsMasafumi Shimoda, Kazunari Yamana, Ryozo Yano, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 12, 2017
Clinical characteristics of pulmonary Mycobacterium lentiflavum disease in adult patientsKazuma Yagi, Kozo Morimoto, Makoto Ishii, et al.
Medicine|December 10, 2021
In-hospital pulmonary rehabilitation after completion of primary respiratory disease treatment improves physical activity and ADL performance: A prospective intervention studyMasafumi Shimoda, Satoshi Takao, Hiroyuki Kokutou, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 11, 2017
Clinical Significance of Interferon-γ Neutralizing Autoantibodies Against Disseminated Nontuberculous Mycobacterial DiseaseAmi Aoki, Takuro Sakagami, Kazutaka Yoshizawa, et al.
ERJ Open Research|February 23, 2023
Epidemiological characteristics of nontuberculous mycobacteriosis and bronchiectasis: comparative study using national mortality statistics from 1970 to 2015 in JapanKozo Morimoto, Kazuro Iwai, Takashi Yoshiyama, et al.
Diagnostic Microbiology and Infectious Disease|August 15, 2021
Evaluation of IS1245 LAMP in Mycobacterium avium and the influence of host-related genetic diversity on its applicationMwangala Lonah Akapelwa, Thoko Flav Kapalamula, Yuki Ouchi-Aizu, et al.
BMC Infectious Diseases|August 11, 2016
Clinical efficacy and safety of multidrug therapy including thrice weekly intravenous amikacin administration for Mycobacterium abscessus pulmonary disease in outpatient settings: a case seriesHo Namkoong, Kozo Morimoto, Tomoyasu Nishimura, et al.
Chest|September 19, 2023
Activities of Daily Living, Hypoxemia, and Lymphocytes Score for Predicting Mortality Risk in Patients With Pulmonary TBTakeshi Osawa, Masato Watanabe, Kozo Morimoto, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 9, 2025
Clinical characteristics of extrapulmonary nontuberculous mycobacterial disease in Japanese adult patients without HIV: A multicenter retrospective studyShuhei Azekawa, Takanori Asakura, Shunsuke Uno, et al.
Annals of the American Thoracic Society|August 12, 2016
Macrolide-Resistant Mycobacterium avium Complex Lung Disease: Analysis of 102 Consecutive CasesKozo Morimoto, Ho Namkoong, Naoki Hasegawa, et al.
Pageof 20